These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9561564)

  • 1. Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251.
    Neildez O; Le Grand R; Chéret A; Caufour P; Vaslin B; Matheux F; Théodoro F; Roques P; Dormont D
    Res Virol; 1998; 149(1):53-68. PubMed ID: 9561564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
    McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
    J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
    AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of beta-chemokines by bronchoalveolar lavage cells during primary infection of macaques inoculated with attenuated nef-deleted or pathogenic simian immunodeficiency virus strain mac251.
    Caufour P; Le Grand R; Ch Ret A; Neildez O; Th Odoro F; Boson B; Vaslin B; Dormont D
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():767-776. PubMed ID: 10092018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses.
    Marthas ML; Lu D; Penedo MC; Hendrickx AG; Miller CJ
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1455-66. PubMed ID: 11679158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.
    Greenier JL; Miller CJ; Lu D; Dailey PJ; Lü FX; Kunstman KJ; Wolinsky SM; Marthas ML
    J Virol; 2001 Apr; 75(8):3753-65. PubMed ID: 11264364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus.
    Benveniste O; Vaslin B; Le Grand R; Cheret A; Matheux F; Theodoro F; Cranage MP; Dormont D
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3658-63. PubMed ID: 8622992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys.
    Pauza CD; Emau P; Salvato MS; Trivedi P; MacKenzie D; Malkovsky M; Uno H; Schultz KT
    J Med Primatol; 1993; 22(2-3):154-61. PubMed ID: 8411107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus.
    Chakrabarti L; Baptiste V; Khatissian E; Cumont MC; Aubertin AM; Montagnier L; Hurtrel B
    Virology; 1995 Nov; 213(2):535-48. PubMed ID: 7491778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus.
    Sallé B; Brochard P; Bourry O; Mannioui A; Andrieu T; Prevot S; Dejucq-Rainsford N; Dereuddre-Bosquet N; Le Grand R
    J Infect Dis; 2010 Aug; 202(3):337-44. PubMed ID: 20569157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.
    Crotty S; Miller CJ; Lohman BL; Neagu MR; Compton L; Lu D; Lü FX; Fritts L; Lifson JD; Andino R
    J Virol; 2001 Aug; 75(16):7435-52. PubMed ID: 11462016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of ddI-induced reduction of acute SIVmac251 virus load on cytokine profiles in cynomolgus macaques.
    Gigout L; Vaslin B; Matheux F; Caufour P; Neildez O; Chéret A; Lebel-Binay S; Théodoro F; Dilda P; Benveniste O; Clayette P; Le Grand R; Dormont D
    Res Virol; 1998; 149(6):341-54. PubMed ID: 9923010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques.
    Pahar B; Kenway-Lynch CS; Marx P; Srivastav SK; LaBranche C; Montefiori DC; Das A
    Virol J; 2016 Dec; 13(1):200. PubMed ID: 27903274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus.
    Neildez O; Le Grand R; Caufour P; Vaslin B; Chéret A; Matheux F; Théodoro F; Roques P; Dormont D
    Virology; 1998 Mar; 243(1):12-20. PubMed ID: 9527911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
    Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
    AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cynomolgus macaque (Macaca fascicularis) endogenous retrovirus expression following simian immunodeficiency virus infection.
    Marsh AK; Willer DO; Skokovets O; Iwajomo OH; Chan JK; MacDonald KS
    PLoS One; 2012; 7(6):e40158. PubMed ID: 22768246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.
    Binley JM; Clas B; Gettie A; Vesanen M; Montefiori DC; Sawyer L; Booth J; Lewis M; Marx PA; Bonhoeffer S; Moore JP
    Virology; 2000 Apr; 270(1):237-49. PubMed ID: 10772996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.
    Ma ZM; Abel K; Rourke T; Wang Y; Miller CJ
    J Virol; 2004 Dec; 78(24):14048-52. PubMed ID: 15564513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.